Chief Scott Budinger, MD, and the other scientists in Pulmonary and Critical Care Medicine tackle some of the most common — and fatal — medical conditions in the world.
Browsing: Disease Discoveries
A pair of proteins that promote blood vessel formation are associated with the development of severe malaria, and they may be a target for future therapeutics, according to recent research.
Northwestern Medicine scientists identified an enzyme as a potential new target for triple-negative breast cancer, a form of breast cancer that is associated with early tumor recurrence and significantly increased mortality rates.
Northwestern Medicine scientists have identified a protein that acts as a marker for a population of cells that may be an origin for prostate cancers.
A Northwestern Medicine study has identified a gene set that can predict whether a transplanted kidney is at risk of damage and subsequent loss.
Northwestern Medicine scientists have identified a signaling pathway that regulates the behavior of two subtypes of glioblastomas.
A new pathway in the brain can be manipulated to alleviate depression, offering a promising new target for developing a drug that could be effective in individuals for whom other antidepressants have failed.
A 3-D printable ink developed by Northwestern scientists produces synthetic bone implants with unique properties to induce bone regeneration.
Northwestern Medicine scientists continue to demonstrate that a protein called Hrd1 may be an important target for treating autoimmune diseases.
For the last decade, Ronald Ackermann, MD, MPH, has worked on implementing a method to halt diabetes that is both effective for patients and affordable for insurers. He and colleagues have focused on adapting an intervention called the Diabetes Prevention Program.